Navigation Links
Nfocus Neuromedical Announces Acquisition of StarFire Medical
Date:3/6/2008

PALO ALTO, Calif., March 6 /PRNewswire/ -- Nfocus Neuromedical, Inc. announced today that it has completed the acquisition of StarFire Medical, Inc. StarFire Medical is a manufacturer of therapeutic implantable devices for interventional (minimally invasive) treatment of neurovascular disease.

The assets acquired include products such as the DSB (Detachable Silicone Balloon) and the NDSB (Non-Detachable Silicone Balloon), also known as the Endeavor Balloon Catheter, both of which have been cleared for marketing by the FDA and through CE marking in Europe. The DSB is a silicone balloon which is used to treat neurovascular fistulas and aneurysms through endovascular (less-invasive catheter) techniques. The DSB can be navigated to the site of pathology, inflated and detached to produce a permanent embolization for symptomatic carotid-cavernous fistulas and for aneurysm treatment through parent vessel occlusion. The NDSB is a soft silicone balloon attached to a very flexible microcatheter and is used for temporary and test occlusion during endovascular procedures.

The acquisition also included other neurovascular devices and Intellectual Property (IP) of StarFire. The remaining StarFire IP is focused on advanced intracranial aneurysm treatment devices that are in development.

"There has been strong physician interest in having access to these types of products in the United States," stated Martin S. Dieck, President and Chief Executive Officer of Nfocus Neuromedical. "The combination of StarFire's existing FDA-cleared devices and advanced aneurysm cover technology fits perfectly with the Nfocus product platform."

Hemorrhagic Stroke

Hemorrhagic stroke is a critical and often life-threatening event most frequently brought on by a rupturing aneurysm or other vascular malformation. In many cases, open surgery may not be ideal or even possible, but the alternative, current endovascular devices, may not provide permanent treatment. It
'/>"/>

SOURCE Nfocus Neuromedical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Nfocus Neuromedical Receives CE Mark for the CardioVasc(TM) Stent-Graft and Delivery System
2. QED International Associates Announces Changes to the HealthShares(TM) Composite and HealthShares(TM) Cancer Indexes
3. Pharos Innovations Announces First Recipient of National Award for Achievements in Chronic Care Programs and Research
4. Trubion Pharmaceuticals Announces Dates for Fourth-Quarter and Year-End 2007 Earnings Conference Call
5. The Hain Celestial Group Announces the Acquisition of MaraNatha(R) and SunSpire(R) Brands
6. Cardiogenesis Corporation Announces Rescheduled Fourth Quarter and Full Year 2007 Earnings Release
7. Derma Sciences Announces Numerous Clinical Presentations on MEDIHONEY(TM) Wound & Burn Dressings at Upcoming SAWC Conference
8. Milestone Scientific Announces Chicago Dental Societys 143rd Midwinter Meeting Proved Successful
9. Zounds Hearing Enters Moorestown and Announces $225,000 Hearing Partnership With Twilight Wish Foundation
10. Pregis Announces Investor Conference Call to Review 2007 Fourth Quarter and Full Year Financial Results
11. Genoptix Announces Participation at Cowen and Company 28th Annual Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...n. 8 /PRNewswire-USNewswire/ -- Advocates for Yo...lescent sexual and reproductive health, has releas...comes in the U.S. lag far behind those in France, ...sforyouth.org/publications/factsheet/fsest.pdf ). ...nearly nine times higher than that in the Netherla...
(Date:1/8/2009)...ewswire-USNewswire/ -- The current economic downtu...e for expensive long-term care costs, such as nurs... today by America,s Health Insurance Plans (AHIP)....f AHIP, found that 60 percent of women say the eco... long-term care costs. , , "Women have been ...
(Date:1/8/2009)...to extended life spans , , THURSDAY, Jan...chers have linked two previously thought-to-be-sep...ading to more thought that physically getting olde... , Short-circuiting that process might one day...the researchers said. , "There is a genetic pr...
(Date:1/8/2009)...et another reason to use a treadmill desk to pre... Phoenix, AZ (PRWEB) January 8, 2009 -- Yet ... community warning of America,s rising obesity rat...National Cancer Institute completed a study that h...between excess weight gain and ovarian cancer. Whi...
Breaking Medicine News(10 mins):Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 2Health News:U.S. Continues to Lag Behind European Countries in Teen Sexual Health - Cleveland Sex Ed Initiative Takes Promising Science-Based Approach 3Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Researchers Gain Insights Into Aging in Mice 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3
...dents are caught between the Karnataka state gover...r T N Chaturvedi said that the colleges should abi... On the other hand the private medical colleges ha...ssed in the Legislative Assembly amid an Oppositio...
... the Mountain View, Calif.-based company is one of...g child pornography. // Hence Long Island politici...ing billions of dollars from illegal child pornogr...ty Legislature accused Google of paying the websit...
...ld Health Organization says that smoke from cookin...umber of deaths worlds over. // Authorities of the... unclean cooking fuels would pay itself back seven...the opinion that under half of the world's six bil...
...e android was developed by South Korean scientist ...orea Institute of Industrial Technology.// The and...bition at the Seoul Education Culture Center. It w... The special features are that it can understand o...
Other Medicine News:
(Date:1/8/2009)..., UT Southwestern to Identify and Validate Novel G...g with Innovative Gene Expression Platform , , ...WaferGen Biosystems, Inc. (OTC Bulletin Board: WGB...xpression, genotyping, cell biology and stem cell ... research collaboration with the University of Te...
(Date:1/7/2009)..., MEMPHIS, Tenn., Jan. 7 /PRNewswire-USNewswire/ -...hat predict a high likelihood of relapse in childr...gh the researchers caution that further research i...led IKZF1 or IKAROS, lead to leukemia relapse,...future diagnostic tests to assess the risk of trea...
(Date:1/7/2009)..., OXFORD, England, January 7 C...ny focused on allergy and critical care, today,an... achieved in 2008 with,its ToleroMune(R) anti-all...tient recruitment for a further phase II clinical ...y in Canada, has recruited 120 patients with confi...
(Date:1/6/2009)..., ROCKVILLE, Md., Jan. 6 /PRNewswire-USNewswire/ -...al company focused on diseases of epidemic potenti...idate for the treatment of tuberculosis (TB), was ...awarded clinical program contract to Dynport Vacci...ntract, awarded by the National Institute of Aller...
Breaking Medicine Technology:WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 2WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 3WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 4WaferGen and University of Texas Southwestern Medical Center Establish Biomarker Research Collaboration for SmartChip(TM) Real-Time PCR System 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 2Gene Abnormality Found to Predict Childhood Leukemia Relapse 3Gene Abnormality Found to Predict Childhood Leukemia Relapse 4Gene Abnormality Found to Predict Childhood Leukemia Relapse 5Gene Abnormality Found to Predict Childhood Leukemia Relapse 6Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 2Circassia Completes Patient Recruitment for Phase II Clinical Trial of Toleromune(R) Allergy Treatment 3Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 2Sequella Lead Drug Compound SQ109 Selected for Phase 1B Clinical Trial Program 3Helix BioPharma Files Form 20 F Registration Statement With the U S Securities and Exchange Commission 9365 1Helix BioPharma Files Form 20 F Registration Statement With the U S Securities and Exchange Commission 9365 2Helix BioPharma Files Form 20 F Registration Statement With the U S Securities and Exchange Commission 9365 3Youth Service America and UnitedHealth Group Offer HEROES Grants to Fight Childhood Obesity 30653 1Youth Service America and UnitedHealth Group Offer HEROES Grants to Fight Childhood Obesity 30653 2Youth Service America and UnitedHealth Group Offer HEROES Grants to Fight Childhood Obesity 30653 3CAS Registers 40 Millionth Substance in CAS REGISTRY 28SM 29 9364 1CAS Registers 40 Millionth Substance in CAS REGISTRY 28SM 29 9364 2Do you know youre having a stroke 3F 30651 1Do you know youre having a stroke 3F 30651 2
...ans of CTI,s,Programmable, Pulsatile, Passive Tran...Switzerland and TRENTON, N.J., May 03, 2007 /PRNew... today the successful,completion of its first phas...ile, passive transdermal drug/device,combination p...s,clinical data in leading scientific and medical ...
...uvant for Vaccines,against Avian Flu and Other Vir...FirstCall/ -- IR,BioSciences Holdings, Inc. announ... vaccine adjuvant study being performed in,conjunc... host,immune responsiveness above that induced by ...going study, and are a strong,indication that Homs...
Other Medicine Technology:Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 2Successful Human Clinical Trial of Chrono Therapeutic's Drug/Device,Combination Product - ChronoDose 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 2IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 3IR BioSciences Announces Promising Data from Study of Its Compound,Homspera 4
...rally utilized when a surgeon would like to impact...nchors that require the surgeon to pre-drill, the ...n. The only instrument required to implant the Har...s Steel Anchor is packaged sterile with sutures an...
... Nakao, M.D., Smith & Nephew has developed an endo...rs and thumbs due to stenosing tenosynovitis.,Our...se patient discomfort while incorporating the maxi...r direct endoscopic vision. The system and techniq...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai
Medicine Products: